REFERENCES
- Aalto Y, Eriksson L, Seregard S, Larsson O. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 2001; 42(2)313–7, [PUBMED], [INFOTRIEVE], [CSA]
- Brantley M A, Jr, Harbour J W. Deregulation of the Rb and p53 pathways in uveal melanoma. Am J Pathology 2000; 157(6)1795–1801, [CSA]
- Char D H, Kroll S M, Stoloff A, Kaleta-Michaels S, Crawford J B, Miller T R, Howes E L, Jr, Ljung B M. Cytomorphometry of uveal melanoma. Comparison of fine needle aspiration biopsy samples with histologic sections. Anal Quant Cytol Histol 1991; 13: 293–9, [PUBMED], [INFOTRIEVE], [CSA]
- Coleman K, Baak J PA, Van Diest P J, Curran B, Mullaney J, Fenton M, Leader M. DNA ploidy status in 84 ocular melanomas: A study of DNA quantitation in ocular melanomas by flow cytometry and automatic and interactive static image analysis. Human Pathology 1995; 26(1)99–105, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cruz F, 3rd, Rubin B P, Wilson D, Town A, Schroeder A, Haley A, Bainbridge T, Heinrich M C, Corless C L. Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res 2003; 63(18)5761–6, [PUBMED], [INFOTRIEVE], [CSA]
- Damato B. Developments in the management of uveal melanoma. Clin Experiment Ophthalmol 2004; 32(6)639–47, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Edmunds S C, Kelsell D P, Hungerford J L, Cree I A. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Invest Ophthalmol Vis Sci 2002; 43(9)2845–51, [PUBMED], [INFOTRIEVE], [CSA]
- Erol N, Oner U, Artan S, Isksoy S, Yurdakul S. Chromosomal abnormalities, p53 and Bcl-2 expression and clinical outcome in choroidal melanoma. Melanoma Res 2004; 14(6)473–8, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T. Tumor doubling times in metastatic malignant melanoma of the uvea. Tumor progression before and after treatment. Ophthalmology 2000; 107: 1443–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gorringe K L, Chin S F, Pharoah P, Staines J M, Oliveira C, Edwards P A, Caldas C. Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer. Carcinogenesis. Advance E-Publication. 2005
- Gragoudas E. Uveal melanoma: A rare malignancy. Ophthalmology 2000; 107: 1441–2, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hammer H, Toth-Molnar E, Olah J, Dobozy A. Cutaneous dysplastic naevi: a risk factor for uveal melanoma. Lancet 1995; 346: 255–6, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Harbour J W, Brantley M A, Jr, Hollingsworth H, Gordon M. Association between choroidal pigmentation and posterior uveal melanoma in a white population. Br J Ophthalmol 2004; 88(1)39–43, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hearle N, Damato B E, Humphreys J, Wixey J, Green H, Stone J, Easton D F, Houlston R S. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma. Invest Ophthalmol Vis Sci 2003; 44(2)458–62, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Honavar S G, Shields C L, Singh A D, Demirci H, Rutledge B K, Shields J A, Eagle R C, Jr. Two discrete choroidal melanomas in an eye with ocular melanocytosis. Surv Ophthalmol 2003; 47(1)36–41, [CSA], [CROSSREF]
- Infante d e, German-Ribon R, Singh A D, Arevalo J F, Driebe W, Eskin T. Choroidal melanoma with oculodermal melanocytosis in Hispanic patients. Am J Ophthalmol 1999; 128(2)251–3, [CSA], [CROSSREF]
- Kallioniemi A, Kallioniemi O P, Sudar D, Rutovitz D, Gray J W, Waldman F, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258(5083)818–21, [PUBMED], [INFOTRIEVE], [CSA]
- Kannengiesser C, Avril M F, Spatz A, Laud K, Lenoir G M, Bressac-de-Paillerets B. CDKN2A as a uveal and cutaneous melanoma susceptibility gene. Genes Chromosomes Cancer 2003; 38(3)265–68, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Karlsson M, Boeryd B, Carstensen J, Franlund B, Gustafsson B, Kagedal B, Sun X F, Wingren S. Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Europ J Cancer 1996; 32A(2)357–62, [CSA], [CROSSREF]
- Karlsson M, Boeryd B, Carstensen J, Kagedal B, Wingren S. DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas. Br J Cancer 1995; 71: 177–81, [PUBMED], [INFOTRIEVE], [CSA]
- Keilholz U, Goldin-Lang P, Bechrakis N E, Max N, Letsch A, Schmittel A, Scheibenbogen C, Heufelder K, Eggermont A, Thiel E. Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction. Clinical Cancer Res 2004; 10: 1605–12, [CSA], [CROSSREF]
- Kilic E, Bruggenwirth H T, Verbiest M M, Zwarthoff E C, Mooy N M, Luyten G P, de lKlein A. The RAS-BRAF kinase pathway is not involved in uveal melanoma. Melanoma Res 2004; 14(3)203–5, [PUBMED], [INFOTRIEVE], [CSA]
- Kodjikian L, Nguyen K, Lumbroso L, Gauthier-Villars M, Chauvel P, Plauchu H, Sterkers M, Devouassoux M, Grange J D. Familial uveal melanoma: a report on two families and a review of the literature. Acta Ophthalmologica Scandinavica 2003; 81(4)389–5, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Margo C E, Mulla Z, Billiris K. Incidence of surgically treated uveal melanoma by race and ethnicity. Ophthalmology 1998; 105(6)1087–90, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McLean I W, Foster W D, Zimmerman L E, Gamel J W. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983; 96: 502–9, [PUBMED], [INFOTRIEVE], [CSA]
- Merbs S L, Sidransky D. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma. Invest Ophthalmol Vis Sci 1999; 40(3)779–83, [PUBMED], [INFOTRIEVE], [CSA]
- Mooy C, Vissers K, Luyten G, Mulder A, Stijnen T, de lJong P, Bosman F. DNA flow cytometry in uveal melanoma: the effect of preenucleation radiotherapy. Br J Ophthalmol 1995; 79: 174–7, [PUBMED], [INFOTRIEVE], [CSA]
- Mooy C M, de Jong P TVM. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol 1996; 41: 215–28, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nik N A, Glew W B, Zimmerman L E. Malignant melanoma of the choroid in the Nevus of Ota of a black patient. Arch Ophthalmol 1982; 100: 1641–43, [PUBMED], [INFOTRIEVE], [CSA]
- Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh A D, Shields J A, Shields C L, Croce C M, et al. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res 1994; 54: 5269–72, [PUBMED], [INFOTRIEVE], [CSA]
- Onken M D, Worley L A, Ehlers J P, Harbour J W. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004; 64(20)7205–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Parrella P, Caballero O L, Sidransky D, Merbs S L. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Invest Ophthalmol Vis Sci 2001; 42(8)1679–84, [PUBMED], [INFOTRIEVE], [CSA]
- Parrella P, Fazio V M, Gallo A P, Sidransky D. Fine mapping of chromosome 3 in uveal melanoma: Identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2. Cancer Res 2003; 63: 8507–10, [PUBMED], [INFOTRIEVE], [CSA]
- Parrella P, Sidransky D, Merbs S L. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res 1999; 59(13)3032–7, [PUBMED], [INFOTRIEVE], [CSA]
- Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel K H, Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996; 4: 1222–5, 347(9010)[CSA]
- Regan S, Judge H E, Gragoudas E S, Egan K M. Iris color as a prognostic factor in ocular melanoma. Arch Ophthalmol 1999; 117(6)811–14, [PUBMED], [INFOTRIEVE], [CSA]
- Sandinha M T, Farquharson M A, Roberts F. Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation. Br J Ophthalmol 2004; 88(12)1527–32, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schmittel A, Bechrakis N E, Martus P, Mutlu D, Scheibenbogen C, Bornfeld N, Foerster M H, Thiel E, Keilholz U. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma. Europ J Cancer 2004; 40: 2389–95, [CSA], [CROSSREF]
- Scholes A GM, Liloglou T, Maloney P, Hagan S, Nunn J, Hiscott P, Damato B E, Grierson I, Field J K. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma. Invest Ophthalmol Vis Sci 2001; 42(11)2472–7, [PUBMED], [INFOTRIEVE], [CSA]
- Seddon J M, Albert D M, Lavin P T, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983; 101: 1894–99, [PUBMED], [INFOTRIEVE], [CSA]
- Seregard S, Spangberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology 1998; 105(3)485–91, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Singh A D. Uveal melanoma: Implications of tumor doubling time, letter to the editor. Ophthalmol 2001; 108(5)829–30, [CSA]
- Singh A D, De Potter P, Fijal B A, Shields C L, Shields J A, Elston R C. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology 1998; 105(1)195–98, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Singh A D, Rennie I G, Seregard S, Giblin M, McKenzie J. Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 2004; 49(4)419–28, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Singh A D, Shields C L, Shields J A. Prognostic factors in uveal melanoma. Melanoma Res 2001; 11: 255–63, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Singh A D, Shields C L, Shields J A, Sato T. Uveal melanoma in young patients. Arch Ophthalmology 2001; 119(6)925–26, [CSA]
- Singh A D, Topham A. Survival rates with uveal melanoma in the United States: 1973–1997. Ophthalmology 2003; 110: 962–65, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Singh A D, Topham A. Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology 2003; 110: 956–61, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Singh A D, Wang M X, Donoso L A, Shields C L, Potter P D, Shields J A, Elston R C, Fijal B. Familial uveal melanoma, III: Is the occurrence of familial Uveal Melanoma Coincidental?. Arch Ophthalmol 1996; 114: 1101–4, [PUBMED], [INFOTRIEVE], [CSA]
- Spendlove H E, Damato B E, Humphreys J, Barker K T, Hiscott P S, Houlston R S. BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res. 2004; 14(6)449–52, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tschentscher F, Husing J, Holter T, Kruse E, Dresen I G, Jockel K H, Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann D R, Zeschnigk M. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 2003; 63(10)2578–84, [PUBMED], [INFOTRIEVE], [CSA]
- van Ginkel P R, Gee R L, Shearer R L, Subramanian L, Walker T M, Albert D M, Meisner L F, Varnum B C, Polans A S. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res 2004; 64(1)128–34, [PUBMED], [INFOTRIEVE], [CSA]
- Walker T M, Van Ginkel P R, Gee R L, Ahmadi H, Subramanian L, Ksander B R, Meisner L F, Albert D M, Polans A S. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol 2002; 120(12)1719–25, [PUBMED], [INFOTRIEVE], [CSA]
- Weber A, Hengge U R, Urbanik D, Markwart A, Mirmohammadsaegh A, Reichel M B, Wittekind C, Wiedemann P, Tannapfel A. Absence of mutations of the BRAF gene and constitutive activation of extracellular-regulated Kinase in Malignant Melanomas of the Uvea. Laboratory Investigation 2003; 83(12)1771–6, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- White V A, Chambers J D, Courtright P D, et al. Correlation of cytogenetic abnormalities with outcome of patients with uveal melanoma. Cancer 1998; 83: 354–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- White V A, McNeil B K, Horsman D E. Acquired homozygosity (isodisomy) of chromosome 3 in uveal melanoma. Cancer Genet Cytogenet 1998; 102: 40–5, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wodicka L, Dong H, Mittmann M, Ho M H, Lockhart D J. Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol 1997; 15(13)1359–67, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zuidervaart W, van der Velden P A, Hurks M H, van Nieuwpoort F A, Out-Luiting C J, Singh A D, Frants R R, Jager M J, Gruis N A. Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development. Br J Cancer 2003; 89: 1914–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]